Faculty profile

Ranjani Somayaji

ResearcherInfectious DiseasesMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Ranjani Somayaji

Researcher

Infectious Diseases

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
1 publication in the last five years, latest in 2022.
Principal investigator on 2 research grants (2 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

173

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Bacteremia Bloodstream Infection Endocarditis Enterococcus Platform Trial Randomized Controlled Trial Clinical Trial Oral Antibiotics

Latest papers

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial
CANADIAN MEDICAL ASSOCIATION JOURNAL · 2022

All 1 publications

Latest funding

Treatment of Enterococcal Bacteremia Platform (TENT)
CIHR · 2026 · Principal investigator
$1,946,926
An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform
CIHR · 2024 · Co-investigator
$1,683,000
A Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP)
CIHR · 2024 · Principal investigator
$1,705,952

All 7 grants and awards

Treatment of Enterococcal Bacteremia Platform (TENT)

Principal investigatorCIHR2026Project Grant

Principal investigators: Lee, Todd C; Briggs, Simon; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Golchi, Shirin; Goodman, Anna L; Hasse, Barbara; Kuehl, Richard; Martin, Yonas; McDonald, Emily G; Mertz, Dominik; Paul, Mical; Sligl, Wendy I; Somayaji, Ranjani; Speich, Benjamin; Tong, Steven; Walls, Genevieve

Keywords: Bacteremia; Bloodstream Infection; Endocarditis; Enterococcus; Platform Trial; Randomized Controlled Trial

$1,946,926

An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform

Co-investigatorCIHR2024Project Grant

Principal investigators: Lee, Todd C; Benedetti, Andrea; Bhagani, Sanjay; Boyles, Tom; Butler-Laporte, Guillaume; Cheng, Matthew P; McDonald, Emily G; McGuinty, Michaeline; Nakashima, Kei; Schwartz, Ilan S; Slavin, Monica; So, Miranda; Tan, Darrell H; Yong, Michelle

Keywords: Immunomodulation; Platform Trial; Pneumocystis; Pneumonia; Randomized Controlled Trial; Secondary Prophylaxis; Treatment

$1,683,000

A Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP)

Principal investigatorCIHR2024Project Grant

Principal investigators: Cheng, Matthew P; Bai, Anthony D; Daley, Peter; Daneman, Nick; Grant, Jennifer; Lawandi, Alexander; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Somayaji, Ranjani; Wuerz, Terence

Keywords: Bacteremia; Bloodstream Infection; Clinical Trial; Oral Antibiotics; Staphylococcus Aureus

$1,705,952

Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)

Co-investigatorCIHR2022Operating Grant: Clinical Trials Projects

Principal investigators: Lee, Todd C; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Johnstone, Jennie; Lawandi, Alexander; Lye, David C; McDonald, Emily G; Paul, Mical; Tong, Steven; Walls, Genevieve; Wuerz, Terence

Keywords: Combination Therapy; Endocarditis; Randomized Controlled Trial; Staphylococcus Aureus Bacteremia

$1,999,745

Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)

Co-investigatorCIHR2022Operating Grant: Clinical Trials Projects - Indirect Costs

Keywords: Combination Therapy; Endocarditis; Randomized Controlled Trial; Staphylococcus Aureus Bacteremia

$499,936

PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)

Co-investigatorCIHR2021Project Grant

Principal investigators: Lee, Todd C; Cheng, Matthew P; McDonald, Emily G

Keywords: Antibiotic Resistance; Bacteremia; Bloodstream Infection; E. Coli; Esbl; K. Pneumoniae; Non-Inferiority; Pragmatic; Randomized Controlled Trial

$371,024

The S. aureus Network Adaptive Platform Trial (SNAP) Canada: A Randomized Controlled Trial for Penicillin-susceptible, Methicillin-susceptible, and Methicillin-resistant Staphylococcus aureus Bloodstream Infections in Hospitalized Patients

Co-investigatorCIHR2020Project Grant

Principal investigators: Cheng, Matthew P; Daneman, Nick; Johnstone, Jennie; Lee, Todd C

Keywords: Bacteremia; Randomized Controlled Trial; Staphylococcus Aureus

$1,139,852

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Ranjani Somayaji

Research

Latest papers

Latest funding

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

Treatment of Enterococcal Bacteremia Platform (TENT)

An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform

A Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP)

Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)

Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)

PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)

The S. aureus Network Adaptive Platform Trial (SNAP) Canada: A Randomized Controlled Trial for Penicillin-susceptible, Methicillin-susceptible, and Methicillin-resistant Staphylococcus aureus Bloodstream Infections in Hospitalized Patients

Frequent collaborators

Jennifer Tsang

Ruxandra Pinto

Jennifer Grant

Ameeta Singh

Peter Daley

Santiago Perez Patrigeon

Cecilia Costiniuk

Alexis Turgeon

Wendy Sligl

Michael Silverman

Michael Silverman

Jennifer Tsang

Stephen Giilck

Erick Duan

Sergio Borgia

Karim Ali

Ryan Zarychanski

Alexis Turgeon

Marina Klein

Francois Lamontagne

Marina Klein

Nick Daneman

Shane English

Alexis Turgeon

Patricia Fontela

Cecilia Costiniuk

Srinivas Murthy

John Conly

Makeda Semret

Madeleine Durand

Marina Klein